Association between vascular endothelial growth factor promoter polymorphisms and the risk of recurrent implantation failure

  • Authors:
    • Sung Han Shim
    • Jung Oh Kim
    • Young Joo Jeon
    • Hui Jeong An
    • Hyun Ah Lee
    • Ji Hyang Kim
    • Eun Hee Ahn
    • Woo Sik Lee
    • Nam Keun Kim
  • View Affiliations

  • Published online on: December 15, 2017     https://doi.org/10.3892/etm.2017.5641
  • Pages: 2109-2119
Metrics: HTML 0 views | PDF 0 views     Cited By (CrossRef): 0 citations

Abstract

The objective of the present study was to investigate the association between recurrent implantation failure (RIF) and vascular endothelial growth factor (VEGF) gene polymorphisms that are associated with various female infertility disorders. A total of 116 women diagnosed with RIF and 218 control subjects were genotyped for the VEGF ‑2578C>A, ‑1154G>A, ‑634C>G and 936C>T polymorphisms using a polymerase chain reaction‑restriction fragment length polymorphism assay. The VEGF ‑2578AA genotype was associated with an increased prevalence (≥4) of RIF [adjusted odds ratio (AOR)=2.77; 95% confidence interval (CI)=1.10‑7.02; P=0.031], whereas the VEGF ‑634CG+GG genotype was associated with an increased incidence of total RIF (AOR=2.03; 95% CI=1.02‑4.05; P=0.044) and ≥4 RIF (AOR=3.16; 95% CI=1.19‑8.37; P=0.021). The results of the haplotype analysis indicated that ‑2578A/‑1154A/‑634G/936C (AOR=1.76; 95% CI=1.03‑3.00; P=0.040 for total RIF and AOR=2.11; 95% CI=1.12‑3.97; P=0.021 for ≥4 RIF) was associated with the occurrence of RIF. In addition, it was revealed that there was a significant difference in serum prolactin level associated with the VEGF ‑634C>G polymorphism (P=0.013). Therefore the findings of the present study indicate that the VEGF ‑2578AA genotype, ‑634G allele and ‑2578A/‑1154A/‑634G/936C haplotype may be genetic markers for susceptibility to RIF. However, further studies on VEGF promoter polymorphisms that include an independent randomized‑controlled population are required to confirm these results.

Related Articles

Journal Cover

February 2018
Volume 15 Issue 2

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Shim, S.H., Kim, J.O., Jeon, Y.J., An, H.J., Lee, H.A., Kim, J.H. ... Kim, N.K. (2018). Association between vascular endothelial growth factor promoter polymorphisms and the risk of recurrent implantation failure. Experimental and Therapeutic Medicine, 15, 2109-2119. https://doi.org/10.3892/etm.2017.5641
MLA
Shim, S. H., Kim, J. O., Jeon, Y. J., An, H. J., Lee, H. A., Kim, J. H., Ahn, E. H., Lee, W. S., Kim, N. K."Association between vascular endothelial growth factor promoter polymorphisms and the risk of recurrent implantation failure". Experimental and Therapeutic Medicine 15.2 (2018): 2109-2119.
Chicago
Shim, S. H., Kim, J. O., Jeon, Y. J., An, H. J., Lee, H. A., Kim, J. H., Ahn, E. H., Lee, W. S., Kim, N. K."Association between vascular endothelial growth factor promoter polymorphisms and the risk of recurrent implantation failure". Experimental and Therapeutic Medicine 15, no. 2 (2018): 2109-2119. https://doi.org/10.3892/etm.2017.5641